amphotericin brands
3 registered brands containing amphotericin in Zimbabwe.
2D structure
Amphotericin
PubChem CID 5280965Molecular formula: C47H73NO17
Amphotericin B is fungistatic or fungicidal depending on the concentration obtained in body fluids and the susceptibility of the fungus. The drug acts by binding to sterols (ergosterol) in the cell membrane of susceptible fungi. This creates a transmembrane channel, and the resultant change in membrane permeability allowing leakage of intracellular components. Ergosterol, the principal sterol in the fungal cytoplasmic membrane, is the target site of action of amphotericin B and the azoles. Amphotericin B, a polyene, binds irreversibly to ergosterol, resulting in disruption of membrane integrity and ultimately cell death. Amphotericin B usually is fungistatic in action at concentrations obtained clinically, but may be fungicidal in high concentrations or against very susceptible organisms. Amphotericin B exerts its antifungal activity principally by binding to sterols (e.g., ergosterol) in the fungal cell membrane. As a result of this binding, the cell membrane is no longer able to function as a selective barrier and leakage of intracellular contents occurs. Cell death occurs in part as a result of permeability changes, but other mechanisms also may contribute to the in vivo antifungal effects of amphotericin B against some fungi. Amphotericin B is not active in vitro against organisms that do not contain sterols in their cell membranes (eg, bacteria). Binding to sterols in mammalian cells (such as certain kidney cells and erythrocytes) may account for some of the toxicities reported with conventional amphotericin B therapy. At usual therapeutic concentrations of amphotericin B, the drug does not appear to hemolyze mature erythrocytes, and the anemia seen with conventional IV amphotericin B therapy may result from the action of the drug on actively metabolizing and dividing erythropoietic cells. ...Nephrotoxicity associated with conventional IV amphotericin B appears to involve several mechanisms, including a direct vasoconstrictive effect on renal arterioles that reduces glomerular and renal tubular blood flow and a lytic action on cholesterol-rich lysosomal membranes of renal tubular cells. ...
Source: PubChem (NCBI) ยท compound 5280965
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| AMPHO-B INJECTABLE; INJECTION |
Vhb Medi Sciences | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| AMPHONEX POWDER/INJECTABLE; INJECTION |
Bharat Serums And Vaccines | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| AMPHOTRET POWDER/INJECTABLE; INJECTION |
Bharat Serums & Vaccines | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |